false 2024-12-15 0001790169 00-0000000 Flora Growth Corp. 0001790169 2024-12-15 2024-12-15

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
___________________________

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): (December 15, 2024)

FLORA GROWTH CORP.
(Exact name of registrant as specified in its charter)

Ontario 001-40397 Not Applicable
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification No.)

3230 W. Commercial Boulevard, Suite 180
Fort Lauderdale, Florida, United States 33309
(Address of principal executive offices) (ZIP Code)

Registrant’s telephone number, including area code: (954) 842-4989

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class   Trading Symbols   Name of each exchange on which registered
Common Shares, no par value   FLGC   NASDAQ Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b -2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.


Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

On December 15, 2024, Flora Growth Corp. (the "Company") granted a total of 1,235,000 Restricted Stock Awards (the "RSAs") and 440,000 Stock Appreciation Rights ("SARs") to officers, directors, employees and consultants of the Company (collectively, the "Grantees") pursuant to its 2022 Incentive Compensation Plan, as amended on June 6, 2023 and August 14, 2024 and Form S-8 Registration Statement (File No. 333-282022). The following tables summarize the terms and conditions of the grants of RSAs and SARs:

Plan Participant

Role

Number of
RSAs granted

Vesting Date

Clifford Starke

Chief Executive Officer

900,000

December 15, 2024

Sammy Dorf

Executive Chairman

250,000

December 15, 2024

Edward Woo

Director

50,000

December 15, 2024

Consultants

35,000

December 15, 2024


Plan Participant

Role

Number of
SARs
granted

Exercise Price

Expiry Date

Vesting
Date

Dany Vaiman

Chief Financial Officer

372,500

$1.30

December 15, 2034

December 15, 2024

Harold Wolkin

Director

30,000

$1.30

December 15, 2034

December 15, 2024

Manfred Leventhal

Director

5,000

$1.30

December 15, 2034

December 15, 2024

Employees

32,500

$1.30

December 15, 2034

December 15, 2024

Each Grantee receiving RSAs entered into a Restricted Stock Award Agreement with respect to their grant of RSAs (each, a "Restricted Stock Award Agreement") and each Grantee receiving SARs entered into a Stock Appreciation Rights Agreement with respect to their grant of SARs (each, a "Stock Appreciation Rights Agreement") with the Company, as applicable.

The foregoing descriptions of the RSAs and SARs do not purport to be complete and are qualified in their entirety by reference to the provisions of the Form of Restricted Stock Award Agreement and the Form of Stock Appreciation Rights Agreement, as applicable, each of which are filed as Exhibit 10.1 and Exhibit 10.2, respectively, to this Current Report and incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)  Exhibits

10.1# Form of Restricted Stock Award Agreement dated December 15, 2024
10.2# Form of Stock Appreciation Rights Agreement dated December 15, 2024
104 Cover Page Interactive Data File

#  Management contract or compensation plan or arrangement.


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

  FLORA GROWTH CORP.
     
Date: December 17, 2024 By: /s/ Clifford Starke
  Name: Clifford Starke
  Title: Chief Executive Officer



FLORA GROWTH CORP.

2022 INCENTIVE COMPENSATION PLAN

NOTICE OF GRANT OF SHARES OF RESTRICTED STOCK

Notice is hereby given of the following grant by Flora Growth Corp., (the "Company"), of the number of Shares of Restricted Stock specified below pursuant to the Flora Growth Corp. 2022 Incentive Compensation Plan (the "Plan"), and subject to the terms and conditions set forth in this Notice, the attached Restricted Stock Award Agreement (the "Award Agreement") and the Plan.

Grant Date: December 15, 2024

Number of Shares of Restricted Stock: _______________

Vesting Schedule: The Shares granted pursuant to this Notice shall vest based upon the following schedule.

Percentage of Shares that Vest

Vesting Date

100%

December 15, 2024

Acceleration of Vesting Upon Change in Control.  In the event that a Change in Control of the Company occurs during the Participant's Continuous Service, the Shares subject to this Notice shall become immediately vested as of the date of the Change in Control. Notwithstanding the foregoing, if in the event of a Change in Control the successor company assumes or substitutes another award for the Shares, then the vesting of the Shares shall not be accelerated as described in this paragraph unless the Board specifies otherwise, provided, however, that in the event the successor company assumes or substitutes another award for the Shares and, within 24 months following the consummation of the Change in Control, the successor company terminates the Participant's employment without Cause or the Participant terminates employment with the Company for Good Reason, the assumed or substituted award shall become fully vested upon the termination of Participant's employment notwithstanding any provision of the assumed or substituted award to the contrary.  For purposes of this paragraph, the Shares shall be considered assumed or substituted for if following the Change in Control the award confers the right to receive, for each Share immediately prior to the Change in Control, the consideration (whether stock, cash or other securities or property) received in the transaction constituting a Change in Control by holders of Shares for each Share held on the effective date of such transaction (and if holders were offered a choice of consideration, the type of consideration chosen by the holders of a majority of the outstanding Shares); provided, however, that if such consideration received in the transaction constituting a Change in Control is not solely common stock of the successor company or its parent or subsidiary, the Committee may, with the consent of the successor company or its parent or subsidiary, provide that the consideration to be received upon the vesting of the Shares shall be solely common stock of the successor company or its parent or subsidiary substantially equal in Fair Market Value to the per share consideration received by holders of Shares in the transaction constituting a Change in Control.  The determination of such substantial equality of value of consideration shall be made by the Committee in its sole discretion and its determination shall be conclusive and binding.


Acknowledgments.  By signing this Notice, the Participant: (a) represents that the Participant has received and read and is familiar with the terms and conditions of this Notice, the Award Agreement, and the Plan (b) accepts the Shares subject to all of the terms and conditions of this Notice, the Award Agreement, and the Plan, and (c) agrees to accept as binding, conclusive and final all decisions or interpretations of the Committee upon any questions arising under this Notice, the Award Agreement, or the Plan.  Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Award Agreement or the Plan.

No Employment or Service Contract.  Nothing in this Notice, the Award Agreement, or the Plan shall confer upon the Participant any right to continue in Continuous Service for any period of specific duration or interfere with or otherwise restrict in any way the rights of the Company (or any Related Entity employing or retaining Participant) or of Participant, which rights are hereby expressly reserved by each, to terminate the Participant's Continuous Service at any time for any reason, with or without Cause.

Definitions.  All capitalized terms in this Grant Notice shall have the meaning assigned to them in this Grant Notice, the Award Agreement, or in the Plan.

Dated: December 15, 2024 

FLORA GROWTH CORP.

By: __________________________________

 Name: Clifford Starke

 Title: Chief Executive Officer

PARTICIPANT

_______________

Signature: ____________________________


FLORA GROWTH CORP.

RESTRICTED STOCK AWARD AGREEMENT

1. Grant of Shares of Restricted Stock.  Flora Growth Corp., a Canadian corporation (together with any successor thereto, the "Company"), has granted to the individual (the "Participant") named in the Notice of Grant of Shares of Restricted Stock (the "Notice") to which this Restricted Stock Award Agreement (as modified or amended, the "Award Agreement") is attached, a certain number of Shares of Restricted Stock upon the terms and conditions set forth in the Notice and this Award Agreement. The Shares have been granted pursuant to and shall in all respects be subject to the terms and conditions of the Flora Growth Corp. 2022 Incentive Compensation Plan (the "Plan"), the provisions of which are incorporated herein by reference.  Unless otherwise defined herein, capitalized terms shall have the meanings assigned to such terms in the Notice or the Plan.

2. Vesting of Shares.

(a) ‍‍General Vesting.  Except as otherwise provided in Sections 2(b) and 3 hereof, the Shares shall become vested in the amounts, at the times and upon the conditions set forth in the Notice, provided that the Continuous Service of the Participant continues through and on the applicable Vesting Date set forth in the Notice:  There shall be no proportionate or partial vesting of Shares in or during the months, days or periods prior to each Vesting Date, and all vesting of Shares shall occur only on the applicable Vesting Date.

(b) Acceleration of Vesting at Company Discretion.  Notwithstanding any other term or provision of this Award Agreement, the Committee shall be authorized, in its sole discretion, based upon its review and evaluation of the performance of the Participant and of the Company, to accelerate the vesting of any Shares under this Award Agreement, at such times and upon such terms and conditions as the Committee shall deem advisable.

(c) ‍‍Definitions.  For purposes of this Award Agreement, the following terms shall have the meanings indicated:

(i) "Non-Vested Shares" means any portion of the Shares subject to this Award Agreement that has not become vested pursuant to the Notice and this Section 2.

(ii) "Vested Shares" means any portion of the Shares subject to this Award Agreement that is and has become vested pursuant to the Notice and this Section 2.

3. Forfeiture of Non-Vested Shares.  If the Participant's Continuous Service with the Company and the Related Entities is terminated for any reason, any Shares that are not Vested Shares, and that do not become Vested Shares pursuant to the Notice and Section 2 hereof as a result of such termination, shall be forfeited and automatically terminate immediately upon termination of the Participant's Continuous Service without any payment to the Participant.  If the Participant's Continuous Service is terminated by the Company or a Related Entity for Cause, all Vested Shares and Non-Vested Shares shall be forfeited immediately upon such termination of Continuous Service without any payment to the Participant.  The Committee shall have the power and authority to determine whether or not Cause exists with respect to any termination and to enforce on behalf of the Company any rights of the Company under this Award Agreement in the event of the Participant's forfeiture of Vested Shares or Non-Vested Shares pursuant to this Section 3. 

4. Settlement of the Shares

(a) ‍‍Form and Time of Settlement.  Upon the execution of this Award Agreement, unvested Shares shall be delivered to the Company's transfer agent to be held in the Participant's name.  In the event that the Shares become vested in accordance with the Notice and Section 2 hereof, then within 30 days after the date (the "Vesting Date") on which vesting occurs the Vested Shares shall be settled by the transfer agent's delivery of Shares (rounded down to the nearest whole Share), equal to the number of Shares that have become vested, less any Shares required to be withheld to satisfy any federal, state, local, or foreign income and/or employment taxes that the Company determines it is required to withhold with respect to the Vested Shares and/or any Shares delivered in settlement of the Vested Shares.

(b) Legends.  All stock certificates reflecting the Shares that are delivered in settlement of the Vested Shares shall bear such legends that the Committee shall deem necessary and appropriate or which are otherwise required or indicated pursuant to applicable law, the Company's certificate of incorporation or bylaws or any agreement to which the Participant is a party to or is otherwise bound.

(c) Restrictions on Transfer of Shares.  In no event other than pursuant to a reduction by the Company in the number of Shares otherwise deliverable upon the settlement of a Share for the purpose of satisfying any applicable tax withholding requirement may Shares acquired upon the settlement of a Share be transferred by the Participant before the date that is 180 days after the date on which the Company consummates an initial public offering of Shares to the public pursuant to an effective registration statement on Form S-1 filed with the U.S. Securities and Exchange Commission pursuant to the Securities Act of 1933, as amended.


5. Rights with Respect to Shares.

(a) Rights as Shareholder Before Vesting.  Except as otherwise provided in this Section 5, the Participant shall have all rights, benefits or entitlements with respect to the Shares granted pursuant to the certificate of incorporation or bylaws of the Company, or as otherwise available under applicable law from the date on which the Shares are transferred to the transfer agent to be held in the Participant's name.   

(b) ‍‍Adjustments to Shares.  If at any time while this Award Agreement is in effect, there shall be any increase or decrease in the number of issued and outstanding Shares through the declaration of a stock dividend or through any recapitalization resulting in a stock split-up, combination or exchange of Shares, then and in that event, the Committee shall make any adjustments it deems fair and appropriate, in view of such change, in the number of Shares subject to this Award Agreement.  If any such adjustment shall result in a fractional Share, such fraction shall be disregarded.

(c) ‍‍No Restriction on Certain Transactions.  Notwithstanding any term or provision of this Award Agreement to the contrary, the existence of this Award Agreement, or of any outstanding Shares awarded pursuant to the Notice, shall not affect in any manner the right, power or authority of the Company or any Related Entity to make, authorize or consummate: (i) any or all adjustments, recapitalizations, reorganizations or other changes in the Company's or any Related Entity's capital structure or business; (ii) any merger, consolidation or similar transaction by or of the Company or any Related Entity; (iii) any offer, issue or sale by the Company or any Related Entity of any capital stock of the Company or any Related Entity, including any equity or debt securities, or preferred or preference stock that would rank prior to or on parity with the Shares and/or that would include, have or possess other rights, benefits and/or preferences superior to those that such Shares includes, has or possesses, or any warrants, options or rights with respect to any of the foregoing; (iv) the dissolution or liquidation of the Company or any Related Entity; (v) any sale, transfer or assignment of all or any part of the stock, assets or business of the Company or any Related Entity; (vi) any dividend or other distribution by the Company or any Related Entity to its stockholders or other owners; or (vii) any other corporate transaction, act or proceeding (whether of a similar character or otherwise).

6. Tax Matters.‍‍

(a) Withholding.  As a condition to the Company's obligations with respect to the Shares (including, without limitation, any obligation to deliver any Shares) hereunder, the Participant shall make arrangements satisfactory to the Company to pay to the Company or any Related Entity that employs the Participant, any federal, state, local or foreign taxes of any kind required to be withheld with respect to the grant, vesting and/or delivery of Shares.  If the Participant shall fail to make the tax payments as are required, the Company shall, to the fullest extent permitted by applicable law, have the right to deduct from any payment of any kind (including the withholding of any Shares that otherwise would be delivered to Participant under this Award Agreement) otherwise due to the Participant any federal, state, local taxes or foreign of any kind required by applicable law to be withheld with respect to such Shares.

(b) Satisfaction of Withholding Requirements.  The Participant may satisfy the withholding requirements with respect to the Shares pursuant to any one or combination of the following methods:

(i) payment in cash; or

(ii) if and to the extent permitted by the Committee, payment by surrendering unrestricted previously held Shares which have a value equal to the required withholding amount or the withholding of Shares that otherwise would be deliverable to the Participant pursuant to this Award.  The Participant may surrender Shares either by attestation or by delivery of a certificate or certificates for Shares duly endorsed for transfer to the Company, and if required with medallion level signature guarantee by a member firm of a national stock exchange, by a national or state bank (or guaranteed or notarized in such other manner as the Committee may require).

(c) Participant's Responsibilities for Tax Consequences.  The tax consequences to the Participant (including without limitation federal, state, local and foreign income or employment tax consequences) with respect to the Shares (including without limitation the grant, vesting and/or forfeiture, or settlement thereof) are the sole responsibility of the Participant.  The Participant shall consult with his or her own personal accountant(s) and/or tax advisor(s) regarding these matters and the Participant's filing, withholding and payment (or tax liability) obligations. 


7. Amendment, Modification & Assignment; Non-Transferability.  This Award Agreement may only be modified or amended in a writing signed by the Company and the Participant.  No promises, assurances, commitments, agreements, undertakings or representations, whether oral, written, electronic or otherwise, and whether express or implied, with respect to the subject matter hereof, have been made by either party which are not set forth expressly in this Award Agreement.  Unless otherwise consented to in writing by the Company, in its sole discretion, this Award Agreement (and Participant's rights hereunder) may not be assigned, and the obligations of Participant hereunder may not be delegated, in whole or in part.  The rights and obligations created hereunder shall be binding on the Participant and his or her heirs and legal representatives and on the successors and assigns of the Company.

8. Acknowledgment of Nature of Award.

In accepting the grant of these Shares, the Participant acknowledges that:

(a) the Plan is established voluntarily by the Company, it is discretionary in nature and may be modified, amended, suspended or terminated by the Company at any time, as provided in the Plan;

(b) the grant of this Award is voluntary, occasional and discretionary and does not create any contractual or other right to receive future awards of Shares, or benefits in lieu of Shares even if Shares have been awarded in the past;

(c) all decisions with respect to future awards, if any, will be at the sole discretion of the Company;

(d) the Participant's participation in the Plan is voluntary;

(e) this Award and any Shares acquired under the Plan, and the income from and value of same, are not part of normal or expected compensation or salary for any purposes, including, but not limited to, calculation of any severance, resignation, termination, redundancy, end of service payments, bonuses, long-service awards, pension or retirement benefits or similar payments unless otherwise provided in the applicable benefit plan;

(f) the future value of the underlying Shares is unknown and cannot be predicted with certainty;

(g) if the Participant receives Shares, the value of such Shares acquired upon settlement may increase or decrease in value; and

(h) no claim or entitlement to compensation or damages arises from termination of this Award, and no claim or entitlement to compensation or damages shall arise from any diminution in value of the Shares resulting from termination of the Participant's Service by the Company or any Related Entity, and the Participant irrevocably releases the Company and its Related Entities from any such claim that may arise. 

9. Securities Laws.  By accepting this Award, the Participant acknowledges that the laws of the United States or other applicable securities laws, and/or the Company's policies regarding trading in its securities, may limit or restrict the Participant's right to buy or sell Shares, including, without limitation, sales of Shares acquired in connection with this Award.  The Participant agrees to comply with all U.S. and any other applicable securities law requirements and Company policies, as such laws and policies are amended from time to time.

10. Data Privacy Notice and Consent. 

(a) The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Participant's personal data as described in this Award Agreement by and among, as applicable, the Company and its Related Entities for the exclusive purpose of implementing, administering and managing the Participant's participation in the Plan.

(b) The Participant understands that the Company, the Related Entities and/or such third party administrator as designated by the Committee in its sole and absolute discretion may hold certain personal information about the Participant, including, but not limited to, the Participant's name, home address and telephone number, date of birth, social insurance or social security number or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Shares or any other entitlement to Shares awarded, canceled, vested, unvested or outstanding in the Participant's favor ("Data"), for the exclusive purpose of implementing, administering and managing the Participant's participation in the Plan.  The Participant understands that Data may be transferred to any third parties assisting in the implementation, administration and management of the Plan, that these recipients may be located in the Participant's country, or elsewhere, and that the recipient's country may have different data privacy laws and protections than the Participant's country.  The Participant understands that, if the Participant resides in the European Economic Area, the Participant may request a list with the names and addresses of any potential recipients of Data by contacting the Participant's local human resources representative.  The Participant authorizes the recipients to receive, possess, use, retain and transfer Data, in electronic or other form, for the purposes of implementing, administering and managing the Participant's participation in the Plan, including any requisite transfer of such Data as may be required to a broker, escrow agent or other third party with whom the Shares may be deposited.  The Participant understands that if the Participant resides in the European Economic Area, Data will be held only as long as is necessary to implement, administer and manage the Participant's participation in the Plan.  The Participant understands that the Participant may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in writing the Participant's local human resources representative.  The Participant understands that refusal or withdrawal of consent may affect the Participant's ability to participate in the Plan.  Further, the Participant understands that the Participant is providing the consents herein on a purely voluntary basis.  If the Participant does not consent, or if the Participant later seeks to revoke the Participant's consent, the Participant's employment status or Service and career with the Company and its Related Entities will not be affected; the only consequence of refusing or withdrawing the Participant's consent is that the Company would not be able to grant the Participant Shares or other awards or administer or maintain such awards.  For more information on the consequences of the Participant's refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact the Participant's local human resources representative.


11. Company's Right of Offset. If the Participant becomes entitled to a distribution of benefits under this Award, and if at such time the Participant has any outstanding debt, obligation, or other liability representing an amount owing to the Company or any of its Related Entities, then the Company or its Related Entities, upon a determination by the Committee, and to the fullest extent permitted by applicable law and not causing a violation of Section 409A of the Code, may offset such amount so owing against the amount of benefits otherwise distributable.  Such determination shall be made by the Committee.

12. Complete Agreement.  The Notice, this Award Agreement, and the Plan, together with those agreements and documents expressly referred to herein, for the purposes referred to therein, embody the complete and entire agreement and understanding between the parties with respect to the subject matter hereof, and supersede any and all prior promises, assurances, commitments, agreements, undertakings or representations, whether oral, written, electronic or otherwise, and whether express or implied, which may relate to the subject matter hereof in any way.

13. Miscellaneous.

(a) No Right to Continued Employment or Service.  This Award Agreement and the grant of Shares hereunder shall not confer, or be construed to confer, upon the Participant any right to employment or service, or continued employment or service, with the Company or any Related Entity.

(b) No Limit on Other Compensation Arrangements.  Nothing contained in this Award Agreement shall preclude the Company or any Related Entity from adopting or continuing in effect other or additional compensation plans, agreements or arrangements, and any such plans, agreements and arrangements may be either generally applicable or applicable only in specific cases or to specific persons.

(c) Severability.  If any term or provision of this Award Agreement is or becomes or is deemed to be invalid, illegal or unenforceable in any jurisdiction or under any applicable law, rule or regulation, then such provision shall be construed or deemed amended to conform to applicable law (or if such provision cannot be so construed or deemed amended without materially altering the purpose or intent of this Award Agreement and the grant of Shares hereunder, such provision shall be stricken as to such jurisdiction and the remainder of this Award Agreement and the Award hereunder shall remain in full force and effect).

(d) No Trust or Fund Created.  Neither this Award Agreement nor the grant of Shares hereunder shall create or be construed to create a trust or separate fund of any kind or a fiduciary relationship between the Company or any Related Entity and the Participant or any other person.  To the extent that the Participant or any other person acquires a right to receive payments from the Company or any Related Entity pursuant to this Award Agreement, such right shall be no greater than the right of any unsecured general creditor of the Company.

(e) Law Governing.  This Award Agreement shall be governed by and construed and enforced in accordance with the internal laws of the State of Delaware (without reference to the conflict of laws rules or principles thereof).

(f) Interpretation.  The Participant accepts the Shares subject to all of the terms, provisions and restrictions of the Notice, this Award Agreement and the Plan.  The undersigned Participant hereby accepts as binding, conclusive and final all decisions or interpretations of the Committee with respect to any questions arising under the Notice, this Award Agreement or the Plan. 


(g) Headings.  Section, paragraph and other headings and captions are provided solely as a convenience to facilitate reference.  Such headings and captions shall not be deemed in any way material or relevant to the construction, meaning or interpretation of this Award Agreement or any term or provision hereof.             

(h) Notices.  Any notice under this Award Agreement shall be in writing and shall be deemed to have been duly given when delivered personally, deposited in the United States mail, registered, postage prepaid,  or sent by means of international courier, and addressed, in the case of the Company, to the Company's principal place of business or the office of its registered agent in the State of Delaware, or in the case of the Participant, to the Participant's last permanent address as shown on the Company's records, subject to the right of either party to designate some other address at any time hereafter in a notice satisfying the requirements of this paragraph.

(i) Non-Waiver of Breach.  The waiver by any party hereto of the other party's prompt and complete performance, or breach or violation, of any term or provision of this Award Agreement shall be effected solely in a writing signed by such party, and shall not operate nor be construed as a waiver of any subsequent breach or violation, and the waiver by any party hereto to exercise any right or remedy which he, she or it may possess shall not operate nor be construed as the waiver of such right or remedy by such party, or as a bar to the exercise of such right or remedy by such party, upon the occurrence of any subsequent breach or violation. 

(j) Counterparts.  This Award Agreement may be executed in two or more separate counterparts, each of which shall be an original, and all of which together shall constitute one and the same agreement.

(k) Section 409A.  It is intended that the provisions of the Notice and this Award Agreement qualify for the exemption from Section 409A of the Code for transfers of restricted property as set forth in Treas. Reg. Section 1.409A-1(b)(6) and the Notice and this Award Agreement shall be interpreted in a manner consistent with (and may be modified by the Committee in its sole and absolute discretion to the extent that the Committee determines that such amendment is necessary or appropriate to comply with) that intent.

(L) CONSTRUCTION. CAPTIONS AND TITLES CONTAINED IN THE NOTICE AND HEREIN ARE FOR CONVENIENCE ONLY AND SHALL NOT AFFECT THE MEANING OR INTERPRETATION OF ANY PROVISION OF THE NOTICE OR THIS AWARD AGREEMENT. EXCEPT WHEN OTHERWISE INDICATED BY THE CONTEXT, THE SINGULAR SHALL INCLUDE THE PLURAL AND THE PLURAL SHALL INCLUDE THE SINGULAR. USE OF THE TERM "OR" IS NOT INTENDED TO BE EXCLUSIVE, UNLE



Stock Appreciation Rights Agreement

This Stock Appreciation Rights Agreement ("SAR Agreement") evidences the grant to _______ (the "Participant") by Flora Growth Corp. (the "Company") of the right to receive shares of Common Stock of the Company (the "Shares") on the terms and conditions provided for below (the "SARs").

1. Grant Date and Term. The date on which the SARs are granted is December 15, 2024 (the "Grant Date"). The term of the SARs is from the Grant Date until the tenth anniversary of the Grant Date, including any post-termination period. For greater clarity, the SARs can be exercised until the tenth anniversary of the Grant Date, irrespective of whether the Participants remains employed by the Company.

2. Number of Shares Subject to SARs; Rights Conferred by Grant of SARs. The number of Shares subject to the SARs is ______. The SARs represent the right, upon exercise, to receive a number of Shares with a fair market value, determined on the date of exercise, equal to the product of (i) the aggregate number of Shares with respect to which this SAR is exercised and (ii) the excess of (A) the fair market value of a Share as of the date of exercise over (B) the SAR Base Price specified below. The fair market value of a share on the date of exercise shall be determined as provided in Section 5 below. The Participant shall not be entitled to receive a cash payment in respect of the Shares underlying the SARs on any dividend payment date for the Shares.

3. Base Price. The Base Price of the SARs is $1.30.

4. Vesting. The SARs shall vest in full on December 15, 2024.

5. Exercise of SARs. the Participant may exercise a vested SAR, in whole or in part, at any time during the term of the SARs by providing written notice to the Company stating the number of shares in respect of which the SAR is being exercised. Such written notice may be delivered in person or by certified mail to the Chief Financial Officer of the Company. Upon exercise, the Participant will receive a number of Shares having a fair market value at the time of exercise equal to the product of (A) the excess of the fair market value of a Share at time of exercise over the Base Price and (B) the number of Shares with respect to which the SARs are exercised. For purposes of this Section 5, fair market value shall be the most recent real time closing price of a Share at the time of exercise of the SAR based on transactions reported on the NASDAQ or other national securities exchange, provided that if the Shares are not then listed and traded on the NASDAQ or other national securities exchange, fair market value shall be what the Company determines in good faith to be the fair market value of a Share at the time of such exercise, using such criteria as it shall determine, in its discretion, to be appropriate for valuation.

6. Transferability of SAR.

The SARs granted hereby shall not be transferable.

7. Withholding Taxes. No later than the date as of which an amount first becomes includible in the gross income of the Participant for federal income tax purposes with respect to the SARs, the Participant shall pay to the Company or make arrangements satisfactory to the Company regarding the payment of, any federal, state, local or foreign taxes of any kind required by law to be withheld with respect to such amount. If approved by the Company in its sole discretion, the minimum required withholding obligations may be settled with Shares, including without limitation Shares otherwise delivered upon exercise of the SARs. The obligations of the Company under this SAR Agreement shall be conditional on such payment, and the Company shall, to the extent permitted by law, have the right to deduct any such taxes from any payment otherwise due to the Participant.


8. Applicability. By executing this SAR Agreement, the Participant expressly acknowledges (i) receipt of this agreement and any current applicable prospectus and (ii) the applicability of all provisions of this agreement to the SARs.

9. General Termination of Employment. This Section 9 sets forth the normal treatment of the SARs following the date on which the employment relationship between Participant and the Company (including any subsidiary or parent of the Company) ceases to exist (the "Date of Termination") where such termination does not result from circumstances described in Section 10 below. Notwithstanding any provision of this Section 9 or ensuing Sections 10 to the contrary, after a Participant's Date of Termination, no SAR may be exercised after the end of its full term specified pursuant to Section 1. In addition, the Participant's SARs, and the rights and obligations set forth herein, are subject to amendment, adjustment or termination and/or Section 13:

(a) Unvested SARs Held on the Date of Termination. Any unvested SARs held by the Participant as of the Date of Termination shall immediately expire.

(b) Post-Termination Exercise and Expiration. the SARs can be exercised until the tenth anniversary of the Grant Date, irrespective of whether the Participants remains employed by the Company. (the "Exercise Deadline"). Any vested but unexercised SARs not exercised on or before the Exercise Deadline shall immediately expire.

10. Death or Disability. In the event that a Participant's Employment is terminated by reason of death or disability (for purposes of this SAR Agreement, "disability" shall mean that the Participant is unable to perform his or her job duties due to a medically diagnosed permanent physical or mental condition), the following shall apply:

(a) Unvested SARs Held on the Date of Termination. Any unvested SARs held by the Participant as of the Date of Termination shall immediately vest.

(b) Post-Termination Exercise and Expiration. The Exercise Deadline for any SARs held by the Participant (or his or her beneficiaries or estate, in the case of death) on the Date of Termination shall be the third anniversary of the Date of Termination. Any unexercised SARs held by the Participant (or his or her beneficiaries or estate, in the case of death) shall expire immediately after the Exercise Deadline.

11. Change in Control. In the event of a Change in Control following which the Common Stock will not continue to be listed for trading on a national securities exchange, the Company shall arrange for the substitution for any unvested SARs with the grant of a replacement award (the "Replacement Award") to Participant of an option or stock appreciation right issued by the surviving or successor entity (or the ultimate parent thereof) in such Change in Control that meets all of the following criteria:

(a) Such Replacement Award shall be denominated in securities listed for trading following such Change in Control on a national securities exchange.


(b) Such Replacement Award shall provide Participant with substantially the same economic value and benefits as provided by this SAR Agreement and the unvested SARs, including (i) an aggregate exercise or base price equal to the aggregate Base Price of the unvested SARs, (ii) an aggregate spread determined immediately after such Change in Control equal to the aggregate spread of the unvested SARs as determined immediately prior to such Change in Control, and (iii) a ratio of exercise price or base price to the fair market value of the stock subject to such Replacement Award, as determined immediately after the Change in Control, that is equal to the ratio of Base Price of the unvested SARs to the Fair Market Value of the Common Stock, as determined immediately prior to the Change in Control. Notwithstanding anything to the contrary contained herein, the substitution of the Replacement Award for the unvested SARs shall be done in a manner that complies with Section 409A of the Code.

(c) Such Replacement Award shall vest on the earlier to occur of the date the SARs would otherwise have vested under the terms of this SAR Agreement and the third anniversary of the Grant Date, subject to Participant's continued employment with the surviving or successor entity (or a direct or indirect subsidiary or ultimate parent thereof) through such date, provided, however, that such Replacement Award will vest immediately if Participant's employment is terminated by the surviving or successor entity Without Cause or by Participant for Good Reason, in either case at any time prior to the date of vesting of such Replacement Award.

(d) Notwithstanding Section 11(c), such Replacement Award shall vest immediately prior to (i) any transaction with respect to the surviving or successor entity (or parent or subsidiary company thereof) of substantially similar character to a Change in Control, or (ii) the securities underlying such Replacement Award ceasing to be listed on a national securities exchange.

12. Modification; Waiver. Except as provided in this SAR Agreement, no provision of this SAR Agreement may be amended, modified, or waived unless such amendment or modification is agreed to in writing and signed by the Participant and by a duly authorized officer of the Company, and such waiver is set forth in writing and signed by the party to be charged, provided that any change that is advantageous to Participant may be made by the Company without Participant's consent or written signature or acknowledgement. No waiver by either party hereto at any time of any breach by the other party hereto of any condition or provision of this SAR Agreement to be performed by such other party shall be deemed a waiver of similar or dissimilar provisions or conditions at the same or at any prior or subsequent time. Participant acknowledges and agrees that the Company has the right to amend an outstanding SAR in whole or in part from time-to-time if the Company believes, in its sole and absolute discretion, such amendment is required or appropriate in order to conform the SAR to, or otherwise satisfy any legal requirement (including without limitation the provisions of Section 409A of the Code). Such amendments may be made retroactively or prospectively and without the approval or consent of the Participant to the extent permitted by applicable law, provided that the Company shall not have any such authority to the extent that the grant or exercise of such authority would cause any tax to become due under Section 409A of the Code.


13. Notices.

If to the Participant:

to the Participant's most recent address on the records of the Company

If to the Company:

Flora Growth Corp.

3230 W. Commercial Boulevard - Suite 180, Fort Lauderdale, Florida, 33309, United States

Attn: Chief Financial Officer

(or to such other address as the party in question shall from time to time designate by written notice to the other parties).

14. Governing Law. Except to the extent that provisions are governed by applicable provisions of the Code or other substantive provisions of federal law, and all SARs made and actions taken thereunder shall be governed by and construed and enforced in accordance with the laws of the Province of Ontario without regard to the principles of conflicts of law thereof.

 

FLORA GROWTH CORP.

 

 

 

 

 

By:

 

Dany Vaiman

 

 

 

Chief Financial Officer


 

 

 

[Participant]

 

 

 

 



v3.24.4
Document and Entity Information Document
Dec. 15, 2024
Document Information [Line Items]  
Document Type 8-K
Document Creation Date Dec. 15, 2024
Document Period End Date Dec. 15, 2024
Amendment Flag false
Entity Registrant Name Flora Growth Corp.
Entity Address, Address Line One 3230 W. Commercial Boulevard, Suite 180
Entity Address, City or Town Fort Lauderdale
Entity Address, State or Province FL
Entity Address, Country US
Entity Address, Postal Zip Code 33309
Entity Incorporation, State Country Name A6
City Area Code 954
Local Phone Number 842-4989
Entity File Number 001-40397
Entity Central Index Key 0001790169
Entity Emerging Growth Company true
Entity Tax Identification Number 00-0000000
Entity Ex Transition Period false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Shares, no par value
Trading Symbol FLGC
Security Exchange Name NASDAQ

Flora Growth (NASDAQ:FLGC)
Historical Stock Chart
Von Nov 2024 bis Dez 2024 Click Here for more Flora Growth Charts.
Flora Growth (NASDAQ:FLGC)
Historical Stock Chart
Von Dez 2023 bis Dez 2024 Click Here for more Flora Growth Charts.